An Empirical Analysis of Primary and Secondary Pharmaceutical Patents in Chile

María José Abud, Bronwyn Hall and Christian Helmers

Department of Economics, Working Paper Series from Department of Economics, Institute for Business and Economic Research, UC Berkeley

Abstract: We analyze the patent filing strategies of foreign pharmaceutical companies in Chile distinguishing between "primary" (active ingredient) and "secondary" patents (patents on modified compounds, formulations, dosages, particular medical uses, etc.). There is prior evidence that secondary patents are used by pharmaceutical originator companies in the U.S. and Europe to extend patent protection on drugs in length and breadth. Using a novel dataset that comprises all drugs registered in Chile between 1991 and 2010 as well as the corresponding patents and trademarks, we find evidence that foreign originator companies pursue similar strategies in Chile. We find a primary to secondary patents ratio of 1:4 at the drug-level, which is comparable to the available evidence for Europe; most secondary patents are filed over several years following the original primary patent and after the protected active ingredient has obtained market approval in Chile. This points toward effective patent term extensions through secondary patents. Secondary patents dominate "older" therapeutic classes like anti-ulcer and anti-depressants. In contrast, newer areas like anti-virals and anti-neoplastics (anti-cancer) have a much larger share of primary patents.

Keywords: Development of treatments and therapeutic interventions; 5.1 Pharmaceuticals; Chemistry; Pharmaceutical; Chile; Drug Industry; Humans; Patents as Topic; Pharmaceutical Preparations; General Science & Technology (search for similar items in EconPapers)
Date: 2015-01-01
References: Add references at CitEc
Citations: View citations in EconPapers (6)

Downloads: (external link)
https://www.escholarship.org/uc/item/9tv8s2rw.pdf;origin=repeccitec (application/pdf)

Related works:
Journal Article: An Empirical Analysis of Primary and Secondary Pharmaceutical Patents in Chile (2015)
Working Paper: An Empirical Analysis of Primary and Secondary Pharmaceutical Patents in Chile (2015)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cdl:econwp:qt9tv8s2rw

Access Statistics for this paper

More papers in Department of Economics, Working Paper Series from Department of Economics, Institute for Business and Economic Research, UC Berkeley Contact information at EDIRC.
Bibliographic data for series maintained by Lisa Schiff ().